Protalix BioTherapeutics, Inc. (PLX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 33.75M | 9.12M | 17.85M | 15.66M | 10.11M | 18.22M | 17.96M | 13.47M | 3.75M | 10.49M | 10.35M | 35.08M | 9.59M | 8.62M | 14.18M | 8.75M | 16.09M | 8.55M | 12.05M | 6.43M |
| Revenue Growth % | 233.73% | -49.93% | -0.6% | 16.21% | 169.82% | 73.74% | 73.6% | -61.59% | -60.91% | 21.69% | -27.06% | 300.72% | -40.39% | 0.8% | 17.66% | 36.19% | 42.09% | -56.15% | 11.71% | -41.4% |
| Cost of Goods Sold | 4.13M | 4.62M | 8.32M | 5.87M | 8.18M | 3.89M | 8.38M | 9.46M | 2.6M | 8.86M | 4.89M | 6.15M | 3.08M | 2.4M | 7.07M | 4.09M | 6.03M | 3.15M | 3.7M | 4.73M |
| COGS % of Revenue | 12.23% | 50.64% | 46.63% | 37.49% | 80.89% | 21.33% | 46.63% | 70.18% | 69.42% | 84.46% | 47.3% | 17.53% | 32.18% | 27.82% | 49.88% | 46.69% | 37.51% | 36.82% | 30.72% | 73.64% |
| Gross Profit | 29.62M | 4.5M | 9.53M | 9.79M | 1.93M | 14.33M | 9.58M | 4.02M | 1.15M | 1.63M | 5.45M | 28.93M | 6.5M | 6.22M | 7.11M | 4.67M | 10.05M | 5.4M | 8.35M | 1.69M |
| Gross Margin % | 87.77% | 49.36% | 53.37% | 62.51% | 19.11% | 78.67% | 53.37% | 29.82% | 30.58% | 15.54% | 52.7% | 82.47% | 67.82% | 72.18% | 50.12% | 53.31% | 62.49% | 63.18% | 69.28% | 26.36% |
| Gross Profit Growth % | 1432.49% | -68.58% | -0.59% | 143.6% | 68.67% | 779.26% | 75.79% | -86.11% | -82.38% | -73.79% | -23.31% | 519.95% | -35.3% | 15.16% | -14.87% | 175.44% | 53.33% | -67.74% | 5.42% | -81.47% |
| Operating Expenses | 8.48M | 9.16M | 7.4M | 8.62M | 6.08M | 7.12M | 5.59M | 6.45M | 6M | 7.25M | 7.34M | 8.51M | 8.96M | 8.71M | 10.23M | 10.19M | 11.92M | 11.11M | 10.24M | 10.86M |
| OpEx % of Revenue | 25.12% | 100.43% | 41.43% | 55.03% | 60.1% | 39.1% | 31.14% | 47.83% | 160.14% | 69.09% | 70.94% | 24.25% | 93.47% | 101.14% | 72.16% | 116.42% | 74.11% | 129.92% | 84.92% | 168.97% |
| Selling, General & Admin | 3.05M | 3.53M | 2.93M | 2.62M | 2.6M | 3M | 2.6M | 3.48M | 3.12M | 4.14M | 3.67M | 4.03M | 3.12M | 3.1M | 2.85M | 2.61M | 3.15M | 0 | 2.95M | 3.17M |
| SG&A % of Revenue | 9.04% | 38.65% | 16.41% | 16.76% | 25.74% | 16.46% | 14.45% | 25.86% | 83.11% | 39.51% | 35.48% | 11.49% | 32.49% | 35.95% | 20.08% | 29.83% | 19.61% | - | 24.51% | 49.34% |
| Research & Development | 5.43M | 5.63M | 4.47M | 5.99M | 3.48M | 4.12M | 3M | 2.96M | 2.89M | 3.1M | 3.67M | 4.47M | 5.85M | 5.62M | 7.39M | 7.58M | 8.77M | 7.64M | 7.28M | 7.69M |
| R&D % of Revenue | 16.08% | 61.77% | 25.02% | 38.27% | 34.36% | 22.64% | 16.69% | 21.98% | 77.03% | 29.58% | 35.47% | 12.76% | 60.98% | 65.19% | 52.08% | 86.59% | 54.5% | 89.38% | 60.41% | 119.64% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 |
| Operating Income | 21.15M | -4.66M | 2.13M | 1.17M | -4.14M | 7.21M | 3.99M | -2.43M | -4.86M | -5.62M | -1.89M | 20.42M | -2.46M | -2.5M | -3.13M | -5.52M | -1.87M | -5.71M | -1.89M | -9.17M |
| Operating Margin % | 62.65% | -51.06% | 11.94% | 7.49% | -40.99% | 39.57% | 22.22% | -18.01% | -129.56% | -53.55% | -18.24% | 58.22% | -25.65% | -28.95% | -22.03% | -63.11% | -11.63% | -66.74% | -15.64% | -142.62% |
| Operating Income Growth % | 610.16% | -164.61% | -46.6% | 148.29% | 14.64% | 228.39% | 311.5% | -111.88% | -97.48% | -125.05% | 39.62% | 469.68% | -31.5% | 56.27% | -65.78% | 39.73% | 49.53% | -300.99% | 26.99% | -309.2% |
| EBITDA | 21.55M | -4.27M | 2.5M | 1.53M | -3.8M | 7.54M | 4.32M | -2.11M | -4.53M | -5.3M | -1.58M | 20.71M | -2.18M | -2.22M | -2.85M | -5.26M | -1.6M | -5.45M | -1.6M | -8.88M |
| EBITDA Margin % | 63.85% | -46.82% | 14.02% | 9.78% | -37.57% | 41.4% | 24.05% | -15.64% | -120.97% | -50.56% | -15.29% | 59.06% | -22.73% | -25.76% | -20.11% | -60.05% | -9.95% | -63.72% | -13.27% | -138.14% |
| EBITDA Growth % | 667.25% | -156.62% | -42.06% | 172.68% | 16.21% | 242.27% | 373.07% | -110.18% | -108.08% | -138.83% | 44.53% | 494.1% | -36.19% | 59.24% | -78.25% | 40.8% | 53.2% | -274.03% | 29.86% | -365.79% |
| D&A (Non-Cash Add-back) | 404K | 387K | 372K | 360K | 346K | 334K | 329K | 319K | 322K | 313K | 305K | 293K | 280K | 275K | 273K | 268K | 270K | 259K | 285K | 288K |
| EBIT | 21.15M | -4.66M | 2.13M | 1.17M | -4.14M | 7.32M | 4.14M | -1.91M | -4.34M | -5.65M | -1.26M | 20.95M | -2.29M | -2.56M | -2.93M | -4.71M | -1.67M | -5.71M | -1.79M | -9.04M |
| Net Interest Income | -5K | -118K | 108K | -511K | 413K | 107K | -148K | 155K | 123K | -811K | 168K | -774K | -477K | -715K | -442K | 190K | -416K | -1.74M | -2.31M | -2.08M |
| Interest Income | 188K | 265K | 288K | 272K | 419K | 113K | 151K | 522K | 513K | -37K | 628K | 531K | 172K | 0 | 197K | 813K | 202K | 0 | 96K | 128K |
| Interest Expense | 193K | 383K | 180K | 783K | 6K | 6K | 299K | 367K | 390K | 774K | 460K | 1.3M | 649K | 715K | 639K | 623K | 618K | 1.74M | 2.41M | 2.2M |
| Other Income/Expense | -5K | -118K | 108K | -511K | 413K | 107K | -148K | 155K | 123K | -811K | 168K | -774K | -477K | -715K | -442K | 190K | -416K | -961K | -2.31M | -2.08M |
| Pretax Income | 21.14M | -4.78M | 2.24M | 661K | -3.73M | 7.32M | 3.84M | -2.27M | -4.73M | -6.43M | -1.72M | 19.65M | -2.94M | -3.21M | -3.57M | -5.33M | -2.29M | -6.67M | -4.2M | -11.24M |
| Pretax Margin % | 62.64% | -52.36% | 12.54% | 4.22% | -36.9% | 40.16% | 21.4% | -16.86% | -126.28% | -61.28% | -16.62% | 56.01% | -30.62% | -37.25% | -25.15% | -60.94% | -14.21% | -77.99% | -34.83% | -174.9% |
| Income Tax | 2.82M | 728K | -116K | 497K | -113K | 822K | 607K | -69K | -138K | -382K | 133K | 308K | 195K | 530K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 13.36% | -15.24% | -5.18% | 75.19% | 3.03% | 11.24% | 15.79% | 3.04% | 2.92% | 5.94% | -7.74% | 1.57% | -6.64% | -16.51% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 18.32M | -5.5M | 2.35M | 164K | -3.62M | 6.49M | 3.24M | -2.2M | -4.59M | -6.04M | -1.85M | 19.34M | -3.13M | -3.74M | -3.57M | -5.33M | -2.29M | -6.67M | -4.2M | -11.24M |
| Net Margin % | 54.27% | -60.34% | 13.19% | 1.05% | -35.79% | 35.65% | 18.02% | -16.35% | -122.6% | -57.64% | -17.9% | 55.14% | -32.66% | -43.4% | -25.15% | -60.94% | -14.21% | -77.99% | -34.83% | -174.9% |
| Net Income Growth % | 606.13% | -184.76% | -27.22% | 107.44% | 21.24% | 207.45% | 274.73% | -111.39% | -46.76% | -61.6% | 48.08% | 462.56% | -36.96% | 43.9% | 15.05% | 52.55% | 58.25% | -1779.35% | 5.36% | -170.87% |
| Net Income (Continuing) | 18.32M | -5.5M | 2.35M | 164K | -3.62M | 6.49M | 3.24M | -2.2M | -4.59M | -6.04M | -1.85M | 19.34M | -3.13M | -3.74M | -3.57M | -5.33M | -2.29M | -6.67M | -4.2M | -11.24M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.22 | -0.07 | 0.03 | 0.00 | -0.05 | 0.09 | 0.03 | -0.03 | -0.06 | -0.08 | -0.02 | 0.21 | -0.05 | -0.07 | -0.07 | -0.11 | -0.05 | -0.15 | -0.09 | -0.25 |
| EPS Growth % | 566.1% | -180.49% | -10.98% | 106.67% | 21.33% | 203.38% | 252.49% | -114.29% | -20% | -13.74% | 68.43% | 290.91% | 0% | 51.47% | 24.08% | 56% | 64.29% | -1339.67% | 34.14% | -92.31% |
| EPS (Basic) | 0.23 | -0.07 | 0.03 | 0.00 | -0.05 | 0.09 | 0.04 | -0.03 | -0.06 | -0.08 | -0.03 | 0.29 | -0.05 | -0.07 | -0.07 | -0.11 | -0.05 | -0.15 | -0.09 | -0.25 |
| Diluted Shares Outstanding | 83.05M | 78.55M | 80.81M | 81.27M | 76.61M | 81.06M | 81.22M | 73.31M | 73.04M | 72.95M | 83.78M | 83.2M | 57.48M | 51.34M | 49.5M | 47.33M | 45.84M | 45.56M | 45.56M | 45.44M |
| Basic Shares Outstanding | 79.85M | 78.55M | 79.28M | 78.66M | 76.61M | 73.55M | 73.55M | 73.31M | 73.04M | 72.95M | 72.28M | 67.16M | 57.48M | 51.34M | 49.5M | 47.33M | 45.72M | 45.28M | 45.56M | 45.44M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |